Explain suspected versus confirmed disease cases, surveillance updates, outbreak response and uncertainty without offering personal medical diagnosis. Coverage is presented with evidence-led, precise with case status, location and reporting dates.
Zuri is a MKNIRALO house editorial byline for source-led coverage of infectious-disease monitoring, health-system preparedness and public-health data around the world. The byline is maintained by MKNIRALO and is not a claim of an independently verified individual.
For publication-wide information about AI assistance, source standards and corrections, see the Transparency page and Editorial Policy. All authors and bylines
Government data reported November 10 put DRC at 11,042 confirmed Bundibugyo Ebola cases and 5,387 deaths; a cumulative milestone cannot determine whether transmission is slowing.
The World Health Organization says the Bundibugyo Ebola outbreak in the Democratic Republic of the Congo had reached 10,668 confirmed cases and 5,198 deaths by 3 November. As transmission continued across 51 health zones, experts recommended two Bundibugyo-specific vaccine candidates for evaluation in the Tumaini trial, subject to national approval.
The Democratic Republic of the Congo had recorded 10,532 confirmed Bundibugyo virus disease cases and 5,126 confirmed deaths as of 1 November, making the outbreak the largest of its kind on record and the second-largest Ebola disease outbreak to date.
WHO's November 6 bulletin records 67 confirmed yellow fever cases and 18 deaths across nine African countries through October 12. Border-area exposure and population movement raise concern, but links between the reported events have not been established.
An attack on Cantine-Aloya killed at least 33 people, according to local accounts, and forced Ebola patients from medical care. The immediate health risk is disrupted containment, not verified new transmission.
Five people recovered and 46 contacts completed monitoring, Kenya said on November 3. Two patients were still being treated, and the country had not begun the final 42-day observation period.
STRIDE-RCT will assess whether blood-based tests can help GPs decide which symptomatic patients need further investigation. It is not a nationwide screening offer, and a positive result will not be a cancer diagnosis.
Two patients in Adamawa tested negative after two laboratory rounds. Nigeria's earlier imported confirmed Ebola case remains part of its official historical count, even though the patient was evacuated to Switzerland.